Hakim Boudrioua
hakimb.bsky.social
Hakim Boudrioua
@hakimb.bsky.social
Microbiologist. Infectious diseases. Drug discovery.
University of Tübingen, Germany
Reposted by Hakim Boudrioua
I am happy to share our latest preprint, spearheaded by Laura Camus. We show that tyrosin-dependent interactions can foster integration of S. aureus into the nasal microbiome. @cmfi.bsky.social @lmumuenchen.bsky.social
www.biorxiv.org/content/10.1...
May 7, 2025 at 11:16 AM
Reposted by Hakim Boudrioua
Happy to share our latest #glycotime work with Sarah, Annabelle and @mariofares.bsky.social Toward Dual-Target Glycomimetics against Two Bacterial Lectins to Fight Pseudomonas aeruginosa–Burkholderia cenocepacia Infections @pubs.acs.org |Journal of Medicinal Chemistry pubs.acs.org/doi/10.1021/...
Toward Dual-Target Glycomimetics against Two Bacterial Lectins to Fight Pseudomonas aeruginosa–Burkholderia cenocepacia Infections: A Biophysical Study
Chronic lung infections caused by Pseudomonas aeruginosa and Burkholderia cenocepacia pose a severe threat to immunocompromised patients, particularly those with cystic fibrosis. These pathogens often...
pubs.acs.org
April 26, 2025 at 5:50 AM
Beautiful structures
The unique #CellEnvelope of #corynebacteria: @tbharat-lab.bsky.social &co map the C. glutamicum cell surface, revealing a patchy S-layer & specific assembly of the PS2 protein, thereby informing our understanding of cell envelopes that contain #MycolicAcids @plosbiology.org 🧪 plos.io/3Y6JNgw
April 23, 2025 at 9:07 PM
Reposted by Hakim Boudrioua
A new synthetic substance, C26, has been identified to inhibit Salmonella's infection process by targeting the central regulator HilD, offering a potential alternative to antibiotics. doi.org/g9fjsr
New pathoblocker can stop Salmonella infections early on
Pathogenic Salmonella injects effector proteins into the cells of the gastrointestinal tract to penetrate and multiply within them.
phys.org
April 15, 2025 at 1:47 AM
Reposted by Hakim Boudrioua
🔬 New pathoblocker is to stop Salmonella infections early on

Possible alternative treatment method for infections with antibiotic-resistant germs.

📖 Study: tinyurl.com/2s3u4hwj

#Pathoblocker #Salmonella #Pathogenicity #AMR @dzif.bsky.social @unituebingen.bsky.social @mpi-bio-fml.bsky.social
April 14, 2025 at 11:29 AM
Reposted by Hakim Boudrioua
🔬 Neuer Pathoblocker stoppt Salmonelleninfektion, bevor sie beginnt

Mögliche alternative Behandlungsmethode für Infektionen mit antibiotikaresistenten Keimen.

Studie: doi.org/10.1126/scia...

#Pathoblocker #Salmonellen #Pathogenität #AMR @dzif.bsky.social @cmfi.bsky.social @mpi-bio-fml.bsky.social
April 14, 2025 at 11:23 AM
Reposted by Hakim Boudrioua
A synthetic substance, C26, has been discovered to halt Salmonella infections early by targeting the HilD regulator. This novel approach could reshape antibiotic resistance treatment. Read the UofTübingen's press release: www.cmfi.uni-tuebingen.de/en/news-even...
April 14, 2025 at 8:40 AM
Reposted by Hakim Boudrioua
New hope against #Salmonella: Researchers from @unituebingen.bsky.social have developed C26, a compound that blocks infections early – targeted, gentle, and without disturbing the microbiome. A promising approach beyond #antibiotics.
doi.org/10.1126/scia...
Discovery of synthetic small molecules targeting the central regulator of Salmonella pathogenicity
Synthetic molecules targeting HilD provide an antivirulence strategy to disrupt Salmonella enterica pathogenicity.
doi.org
April 11, 2025 at 11:19 PM
New research findings!
In a collaborative effort, we report sythetic small molecules that target HilD, the central regulator of Salmonella pathogenicity.
www.science.org/doi/10.1126/...
Discovery of synthetic small molecules targeting the central regulator of Salmonella pathogenicity
Synthetic molecules targeting HilD provide an antivirulence strategy to disrupt Salmonella enterica pathogenicity.
www.science.org
April 14, 2025 at 10:12 AM
Reposted by Hakim Boudrioua
Discovery of a new class of natural antibiotics with a new mode of action to address antimicrobial resistance, a major unmet need
@mcmasteruniversity.bsky.social
@nature.com
www.nature.com/articles/s41...
A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome - Nature
A new lasso peptide antibiotic exhibits broad-spectrum activity against Gram-negative and Gram-positive bacteria by interfering with bacterial protein synthesis, is unaffected by common resistanc...
www.nature.com
March 26, 2025 at 5:48 PM
Reposted by Hakim Boudrioua
Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent antibody response against a pathogen. Could lead to topical vaccines that are applied in a cream. @djenetbousbaine.bsky.social led the charge... @natureportfolio.bsky.social 1/55
December 11, 2024 at 4:29 PM
Open Postdoc position in Tübingen.
Focus on Legionella genetics, membrane protein biogenesis and secretion.
November 20, 2024 at 10:34 PM